The U.S.Atomic Energy Commission Development Program for High-Specific-Activity Isotopes
Author :
Publisher :
Page : 22 pages
File Size : 14,94 MB
Release : 1968
Category :
ISBN :
Author :
Publisher :
Page : 22 pages
File Size : 14,94 MB
Release : 1968
Category :
ISBN :
Author : P. S. Baker
Publisher :
Page : 20 pages
File Size : 39,43 MB
Release : 1966
Category :
ISBN :
Author : U.S. Atomic Energy Commission
Publisher :
Page : 12 pages
File Size : 50,47 MB
Release : 1958
Category : Radioisotopes
ISBN :
Author : U.S. Atomic Energy Commission
Publisher :
Page : 1220 pages
File Size : 22,28 MB
Release : 1960
Category : Nuclear energy
ISBN :
Author : United States. Congress. Joint Committee on Atomic Energy
Publisher :
Page : 782 pages
File Size : 48,12 MB
Release : 1969
Category :
ISBN :
Author : U.S. Atomic Energy Commission. Technical Information Center
Publisher :
Page : 144 pages
File Size : 14,59 MB
Release : 1973
Category : Nuclear energy
ISBN :
Author : United States. Congress. Joint Committee on Atomic Energy
Publisher :
Page : 292 pages
File Size : 39,55 MB
Release : 1960
Category : Nuclear energy
ISBN :
Author : Irvin C. Bupp
Publisher : Routledge
Page : 224 pages
File Size : 19,14 MB
Release : 2019-03-29
Category : Business & Economics
ISBN : 1000007421
Originally published in 1988. This book considers why some public policies succeed and others do not. It looks at the entrepreneurial process that creates public policies and examines whether they prosper or falter because of their political consequences. The programs and personnel of the Atomic Energy Commission are the empirical foundation for these arguments. The data generated by that agency's annual budget-making cycles, collected over time and organised by program, are used as evidence to test some propositions about policy formation within the executive branch of government. The author's concern is with questions of where and how priorities are established in a complex institutional environment. To answer the more fundamental causal question of why some programs prosper while others wither or die, use is made of more historical analysis and comparison of the fortunes of several of AEC's efforts to develop applied nuclear technology.
Author : United States. Congress. Joint Committee on Atomic Energy
Publisher :
Page : 2012 pages
File Size : 36,49 MB
Release : 1965
Category : Nuclear energy
ISBN :
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 264 pages
File Size : 31,85 MB
Release : 2016-11-28
Category : Medical
ISBN : 0309445310
The decay product of the medical isotope molybdenum-99 (Mo-99), technetium-99m (Tc-99m), and associated medical isotopes iodine-131 (I-131) and xenon-133 (Xe-133) are used worldwide for medical diagnostic imaging or therapy. The United States consumes about half of the world's supply of Mo-99, but there has been no domestic (i.e., U.S.-based) production of this isotope since the late 1980s. The United States imports Mo-99 for domestic use from Australia, Canada, Europe, and South Africa. Mo-99 and Tc-99m cannot be stockpiled for use because of their short half-lives. Consequently, they must be routinely produced and delivered to medical imaging centers. Almost all Mo-99 for medical use is produced by irradiating highly enriched uranium (HEU) targets in research reactors, several of which are over 50 years old and are approaching the end of their operating lives. Unanticipated and extended shutdowns of some of these old reactors have resulted in severe Mo-99 supply shortages in the United States and other countries. Some of these shortages have disrupted the delivery of medical care. Molybdenum-99 for Medical Imaging examines the production and utilization of Mo-99 and associated medical isotopes, and provides recommendations for medical use.